Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Forensic Genomics Company Spun-Off From Illumina

A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems. . . . → Read More: Forensic Genomics Company Spun-Off From Illumina

Engineered Insulin-Producing Cells to Be Grown in Lab

A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes. . . . → Read More: Engineered Insulin-Producing Cells to Be Grown in Lab

Vaccines in Development for Opioid Combinations

Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street. . . . → Read More: Vaccines in Development for Opioid Combinations

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

Trial Testing Engineered Virus as Cancer Treatment

A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment

Viruses Removed from Pig Organs for Human Transplants

Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants. . . . → Read More: Viruses Removed from Pig Organs for Human Transplants

Gene-Edited Skin Grafts Shown to Control Glucose Levels

Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet. . . . → Read More: Gene-Edited Skin Grafts Shown to Control Glucose Levels

Gene Editing, Therapy Company Gains $83.5M in Venture Funds

A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds

Engineered Viruses Studied to Improve Plant Traits.

A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought. . . . → Read More: Engineered Viruses Studied to Improve Plant Traits.